Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.
Turco F, Gillessen S, Treglia G, Fizazi K, Smith MR, Tombal B, Cathomas R, Buttigliero C, Di Maio M, Tucci M, Vogl UM.
Turco F, et al.
Prostate Cancer Prostatic Dis. 2023 Dec 14. doi: 10.1038/s41391-023-00775-y. Online ahead of print.
Prostate Cancer Prostatic Dis. 2023.
PMID: 38097723
Review.